Abstract
This is a retrospective review evaluating the treatment of vertigo by theraptique and the efficacy of theraptique for sudden deafness is also investigated in this review. The intravenous injection of 45mg/3ml theraptique had a remarkable effect in the treatment of serious positional vertigo with nausea, vomiting and improved hearing loss remarkably at a dose of 22.5mg/1.5ml in the three patients of the sudden deafness. In the case of diabetes adrenocortical hormone is sometimes difficult to use, but theraptique can be used. Theraptique demonstrated almost no side effects except for vascular pain and slight palpitation. If 2% Xylocaine (lidocaine) 30mg/1.5ml-60mg/3ml was administered in combination with theraptique, then it was observed to relieve vascular pain. When theraptique was administered with physiological saline or glucose (100-250ml), then vascular pain could be avoided without Xylocaine. Some sudden deafness which showed no improvement after the administration of such drugs such as methycobal or Betamethasone, were rapidly relieved after the administration of theraptique. As a useful treatment for vertigo and sudden deafness, adult patients were treated with an intravenous injection of 22.5mg/1.5ml theraptique, 2% Xylocaine 30mg/1.5ml and 20% glucose 20ml gradually in a bed. The patients restedfor about 6 minutes after the injection. This treatment was then administered twice a day in the morning and afternoon if the serious vertigo or the hearing loss did not improve. Theraptique had no effect onthe symptoms of organic vertigo caused by an embolism or on damage to the labyrinth which had been occurred during surgery.
